Clinical trial
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
NCT01376778 · The George Washington University Biostatistics Center, Other · Completed
Key facts
| NCT number | NCT01376778 |
|---|---|
| Title | A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) |
| Official title | A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) |
| Acronym | CMV |
| Lead sponsor | The George Washington University Biostatistics Center, Other |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Congenital Cytomegalovirus Infection, Maternal Cytomegalovirus Infection |
| Intervention type | Drug, Other |
| Interventions | CMV hyperimmune globulin, Placebo |
| Enrollment | 399 |
| Start date | Apr 1, 2012 |
| Primary completion | Oct 1, 2019 |
| Completion | Jun 30, 2021 |
| First posted | Jun 20, 2011 |
| Last update posted | Feb 2, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: